Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Miriah Teeter (NPI 1316141872)

Field	Value
Entity Type	Individual
Organization	Miriah Teeter
Address	8101 E Lowry Blvd Ste 210
City	Denver
State	CO
ZIP	80230
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 11, 2007

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer at the state level: total Medicare revenue is $1.9M and there is no Medicaid billing on file. The absence of any Medicaid activity indicates the provider’s public reimbursement footprint is concentrated entirely in Medicare, so payer-strategy work should treat Medicare as the dominant commercial channel for partnerships or network negotiations.

Revenue is highly concentrated in intravitreal drug administration: the precomputed top 3 Medicare codes account for 78.9% of this provider's total Medicare revenue, with J0178 at $1M (53.6%), J2777 at $320.2K (16.5%), and J2781 at $171K (8.8%). This concentration signals a practice model driven by high-volume retinal injections rather than office visits or broad multimodal ophthalmology services.

The code mix and major billings point to retina-focused therapeutic care: J0178 (1.5K claims, $692 avg paid/claim, $1M revenue) and J2777 (11K claims, $29 avg paid/claim, $320.2K revenue) are the top revenue drivers and are drugs used for intravitreal treatment, while J2781 (1.4K claims, $120 avg paid/claim, $171K revenue) further emphasizes specialized retinal pharmacotherapy. Combined with the presence of surgical codes such as 67028 (1.1K claims, $98 avg paid/claim, $109.9K revenue), the profile is consistent with a retina specialist whose primary revenue stream is procedural injection therapy.

Diagnostic imaging use is elevated relative to peers: 92134 shows 1.9K claims and $57.6K revenue (3.0% of Medicare revenue) and is explicitly noted as "notably above typical national volume for this code." High utilization of retina imaging supports ongoing management of chronic retinal disease and aligns with frequent injection therapy and monitoring.

Competitive standing is mixed across specific services: J0178 ranks #818 of 3204 (74th percentile; typical, unremarkable volume for this code) and J2777 ranks #942 of 2039 (54th percentile; typical, unremarkable volume for this code), indicating modest national participation for the major anti‑VEGF and newer agents. By contrast, J2781 ranks #57 of 490 (88th percentile; typical, unremarkable volume for this code) which places the provider toward the higher end of national peers for that specific intravitreal agent, even though the plain‑language label provided qualifies it as "typical, unremarkable."

There are notable payment characteristics outside the three top drugs: unclassified drug billing J3490 accounts for $89K (4.6% of Medicare revenue) with 52 claims and a $1712 avg paid/claim, suggesting occasional high‑unit‑cost or miscellaneous drug charges that materially contribute to revenue despite low claim counts. Analysts should review those J3490 entries when reconciling drug inventory or mapping drug utilization to revenue drivers.

Operationally, the practice receives a minority of revenue from office E/M and new‑patient evaluations relative to procedural care: 92014 has 755 claims for $68K (3.5% of Medicare revenue) and 92004 has 112 claims for $12.9K (0.7% of Medicare revenue). This split indicates a procedure-first revenue model where clinical visits support, but do not dominate, the Medicare revenue base.

The provider has an established billing history with an NPI enumerated on 2007-06-11 (~19 years ago), which, combined with lifetime Medicare revenue of $1.9M, suggests a sustained, mid‑scale Medicare retinal practice rather than a newly established or very large multi‑provider enterprise. Continuity of enrollment supports stability for longitudinal utilization and contracting analyses.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,500	$690	$1M
J2777	Injection, faricimab‑svoa, 0.1 mg	11,040	$30	$320.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,430	$120	$171K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,120	$100	$109.9K
J3490	Unclassified drugs	50	$1,710	$89K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	760	$90	$68K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,860	$30	$57.6K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	30	$720	$23.6K
J7999	Compounded drug, not otherwise classified	240	$70	$16.4K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	110	$120	$12.9K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Miriah Teeter — 3 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	60	740	$690	$618.3K
J2777	18	40	8,910	$30	$456.1K
J2781	1	10	470	$120	$79.4K
67028	22	80	670	$100	$73.3K
67036	9	30	20	$1,100	$37.3K
J3490	30	60	50	$290	$23.1K
J7999	22	50	230	$70	$21.5K
67041	7	10	10	$1,260	$21.4K
92014	33	670	100	$80	$15.2K
99214	7,095	8,160	80	$80	$11.3K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Miriah Teeter, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Robert Courtney	CO	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Salil Shukla	CO	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Murtaza Adam	CO	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Mimi Liu	CO	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Nancy Christmas	CO	Retina Specialist (Ophthalmology) Physician	$1.8M	$0
Peter Hovland	CO	Ophthalmology Physician	$1.8M	$0
Curtis Hagedorn	CO	Ophthalmology Physician	$1.5M	$0
David Johnson	CO	Specialist	$1.5M	$0
Ashleigh Levison	CO	Retina Specialist (Ophthalmology) Physician	$1.4M	$0
Brian Joondeph	CO	Retina Specialist (Ophthalmology) Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Miriah Teeter, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$25.5M
Total Longterm Care, Inc.	CO	Exclusive Provider Organization	$0	$13M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$8.3M
Lowry Pediatrics, PC	CO	Pediatrics Physician	$0	$4.4M
Stephen Murphy	CO	Rheumatology Physician	$1.4M	$0
Gregory Barron	CO	Rheumatology Physician	$1.4M	$0
Rennie Mccabe	CO	Rheumatology Physician	$1.3M	$0
Vance Bray	CO	Rheumatology Physician	$1.3M	$0
Annemarie Whiddon	CO	Rheumatology Physician	$1.3M	$0
Kim Tyler	CO	Rheumatology Physician	$1.3M	$0

Miriah Teeter — Billing Profile & Reimbursement Data

Sign up for Miriah Teeter — Billing Profile & Reimbursement Data policy alerts

Miriah Teeter — Billing Profile & Reimbursement Data

Sign up for Miriah Teeter — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References